These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22824749)

  • 1. Serum visfatin is elevated in Chinese women with polycystic ovary syndrome, but might not be a reliable predictor of their glucose intolerance.
    Hong Y; Zhao XM; Huang LL; Li L; Chen XL; Yang DZ
    J Biol Regul Homeost Agents; 2012; 26(2):221-9. PubMed ID: 22824749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS.
    Yildiz BO; Bozdag G; Otegen U; Harmanci A; Boynukalin K; Vural Z; Kirazli S; Yarali H
    Reprod Biomed Online; 2010 Jan; 20(1):150-5. PubMed ID: 20159001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma visfatin concentrations in women with polycystic ovary syndrome.
    Chan TF; Chen YL; Chen HH; Lee CH; Jong SB; Tsai EM
    Fertil Steril; 2007 Aug; 88(2):401-5. PubMed ID: 17335820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
    Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
    Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.
    Liang SJ; Liou TH; Lin HW; Hsu CS; Tzeng CR; Hsu MI
    Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1167-72. PubMed ID: 22497305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome.
    Trolle B; Lauszus FF
    Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1192-6. PubMed ID: 16305707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum visfatin in Asian women with polycystic ovary syndrome.
    Jongwutiwes T; Lertvikool S; Leelaphiwat S; Rattanasiri S; Jultanmas R; Weerakiet S
    Gynecol Endocrinol; 2009 Aug; 25(8):536-42. PubMed ID: 19533482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
    Pepene CE
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
    Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
    Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R; Akbay E; Muslu N; Sezer K; Cayan F
    Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.